Neurobiology of Posttraumatic Stress Disorder Dysfunction and Recovery Following Cognitive Processing Therapy

Enrolling by invitation

Conditions studied: Posttraumatic Stress Disorder

In brief

Posttraumatic stress disorder (PTSD) is a significant personal and societal burden. The purpose of this study is to examine genetic, epigenetic, behavioral, and brain activity changes related to PTSD dysfunction and recovery before and after treatment with Cognitive Processing Therapy.

Key facts

Study ID

NCT02695953

Run by

Milissa Kaufman

People needed

130

Starts

2016-03-01

Expected to finish

2027-06-01

Last updated by the study team

2026-06-25

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• PTSD diagnosis, as measured by the Clinician Administered PTSD Scale for DSM-5
• history of chronic childhood trauma due to relational abuse
• Ability to understand and sign informed consent
• Enrollment in CPT program at McLean Hospital
• Both genders, all ethnic backgrounds, age between 18 and 55
• Fluent English speakers
• Normal or Corrected Vision

You may not qualify if…

• History or current schizophrenia spectrum disorder or other psychotic disorders
• History or current bipolar or other related disorders
• Alcohol and/or substance use disorder within the past month
• Metal implants
• Medical or neurological illness (e.g., seizures, head injury in which they experienced a loss of consciousness)
• Positive pregnancy test

Where it is running

• McLean Hospital — Belmont, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.